Search Results - David Viskochil

Refine Results
  1. 1
    Neurofibromatosis Type 1 and tumorigenesis: molecular mechanisms and therapeutic implications

    Neurofibromatosis Type 1 and tumorigenesis: molecular mechanisms and therapeutic implications by Oren N. Gottfried, David Viskochil, William T. Couldwell

    Published 2009
    Get full text
    Artigo
    Save to List
    Saved in:
  2. 2
    The effect of surgical margins on outcomes for low grade MPNSTs and atypical neurofibroma

    The effect of surgical margins on outcomes for low grade MPNSTs and atypical neurofibroma by Nicholas M. Bernthal, Angelica R. Putnam, Kevin B. Jones, David Viskochil, R. Lor Randall

    Published 2014
    Get full text
    Artigo
    Save to List
    Saved in:
  3. 3
    Familial occurrence of schwannomas and malignant rhabdoid tumour associated with a duplication in SMARCB1

    Familial occurrence of schwannomas and malignant rhabdoid tumour associated with a duplication in SMARCB1 by Jeffrey Swensen, J. W. Keyser, Cheryl M. Coffin, Jaclyn A. Biegel, David Viskochil, Marc S. Williams

    Published 2008
    Get full text
    Artigo
    Save to List
    Saved in:
  4. 4
    Variable expression of neurofibromatosis 1 in monozygotic twins

    Variable expression of neurofibromatosis 1 in monozygotic twins by Margaret B. Rieley, David A. Stevenson, David Viskochil, Brad T. Tinkle, Lisa J. Martin, Elizabeth K. Schorry

    Published 2011
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  5. 5
    Motor Proficiency in Children With Neurofibromatosis Type 1

    Motor Proficiency in Children With Neurofibromatosis Type 1 by Barbara Johnson, Bruce A. MacWilliams, John C. Carey, David Viskochil, Jacques DʼAstous, David A. Stevenson

    Published 2010
    Get full text
    Artigo
    Save to List
    Saved in:
  6. 6
    Malignant Peripheral Nerve Sheath Tumors State of the Science: Leveraging Clinical and Biological Insights into Effective Therapies

    Malignant Peripheral Nerve Sheath Tumors State of the Science: Leveraging Clinical and Biological Insights into Effective Therapies by AeRang Kim, Douglas R. Stewart, Karlyne M. Reilly, David Viskochil, Markku Miettinen, Brigitte C. Widemann

    Published 2017
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  7. 7
    The gene encoding the oligodendrocyte-myelin glycoprotein is embedded within the neurofibromatosis type 1 gene.

    The gene encoding the oligodendrocyte-myelin glycoprotein is embedded within the neurofibromatosis type 1 gene. by David Viskochil, Richard Cawthon, P. OʼConnell, Gangfeng Xu, Jane Stevens, Melanie Culver, J Carey, R. White

    Published 1991
    Get full text
    Artigo
    Save to List
    Saved in:
  8. 8
    The Gene Encoding the Oligodendrocyte-Myelin Glycoprotein Is Embedded within the Neurofibromatosis Type 1 Gene

    The Gene Encoding the Oligodendrocyte-Myelin Glycoprotein Is Embedded within the Neurofibromatosis Type 1 Gene by David Viskochil, Richard Cawthon, P. OʼConnell, Gangfeng Xu, Jeff Stevens, Melanie Culver, John C. Carey, R. White

    Published 1991
    Get full text
    Artigo
    Save to List
    Saved in:
  9. 9
    Double Inactivation of NF1 in Tibial Pseudarthrosis

    Double Inactivation of NF1 in Tibial Pseudarthrosis by David A. Stevenson, Holly Zhou, Shadi Ashrafi, Ludwine Messiaen, John C. Carey, Jacques DʼAstous, Stephen D. Santora, David Viskochil

    Published 2006
    Get full text
    Artigo
    Save to List
    Saved in:
  10. 10
    Bone Mineral Density in Children and Adolescents with Neurofibromatosis Type 1

    Bone Mineral Density in Children and Adolescents with Neurofibromatosis Type 1 by David A. Stevenson, Laurie J. Moyer‐Mileur, Mary Murray, Hillarie Slater, Xiaoming Sheng, John C. Carey, Bukhosi Dube, David Viskochil

    Published 2006
    Get full text
    Artigo
    Save to List
    Saved in:
  11. 11
    Epidermal growth factor receptor expression in neurofibromatosis type 1–related tumors and NF1 animal models

    Epidermal growth factor receptor expression in neurofibromatosis type 1–related tumors and NF1 animal models by Jeffrey E. DeClue, Sue C. Heffelfinger, Giovanna Benvenuto, Bo Ling, Shaowei Li, Wen Rui, William C. Vass, David Viskochil, Nancy Ratner

    Published 2000
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  12. 12
    Identification and characterization of transcripts from the neurofibromatosis 1 region: The sequence and genomic structure of EVI2 and mapping of other transcripts

    Identification and characterization of transcripts from the neurofibromatosis 1 region: The sequence and genomic structure of EVI2 and mapping of other transcripts by Richard Cawthon, P. OʼConnell, Arthur M. Buchberg, David Viskochil, Robert B. Weiss, Melanie Culver, Jeffrey Stevens, Nancy A. Jenkins, Neal G. Copeland, R. White

    Published 1990
    Get full text
    Artigo
    Save to List
    Saved in:
  13. 13
    The Use of MEK Inhibitors in Neurofibromatosis Type 1–Associated Tumors and Management of Toxicities

    The Use of MEK Inhibitors in Neurofibromatosis Type 1–Associated Tumors and Management of Toxicities by Laura J. Klesse, Justin T. Jordan, Heather B. Radtke, Tena Rosser, Elizabeth K. Schorry, Nicole J. Ullrich, David Viskochil, Pamela Knight, Scott R. Plotkin, Kaleb Yohay

    Published 2020
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  14. 14
    A Novel Mutation in FGFR3 Causes Camptodactyly, Tall Stature, and Hearing Loss (CATSHL) Syndrome

    A Novel Mutation in FGFR3 Causes Camptodactyly, Tall Stature, and Hearing Loss (CATSHL) Syndrome by Reha M. Toydemir, Anna E. Brassington, Pınar Bayrak‐Toydemir, Patrycja A. Krakowiak, Lynn B. Jorde, Frank G. Whitby, Nicola Longo, David Viskochil, John C. Carey, Michael J. Bamshad

    Published 2006
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  15. 15
    Genotype‐phenotype relationships in mucopolysaccharidosis type I (MPS I): Insights from the International MPS I Registry

    Genotype‐phenotype relationships in mucopolysaccharidosis type I (MPS I): Insights from the International MPS I Registry by Lorne A. Clarke, Roberto Giugliani, Nathalie Guffon, Simon Jones, Hillary A. Keenan, María Verónica Muñoz‐Rojas, Torayuki Okuyama, David Viskochil, Chester B. Whitley, Frits A. Wijburg, Joseph Muenzer

    Published 2019
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  16. 16
    Bortezomib in the rapid reduction of high sustained antibody titers in disorders treated with therapeutic protein: lessons learned from Pompe disease

    Bortezomib in the rapid reduction of high sustained antibody titers in disorders treated with therapeutic protein: lessons learned from Pompe disease by Suhrad G. Banugaria, Sean N. Prater, Judeth K. McGann, Jonathan Feldman, Jesse A. Tannenbaum, Carrie Bailey, Renuka Gera, Robert L. Conway, David Viskochil, Joyce A. Kobori, Amy S. Rosenberg, Priya S. Kishnani

    Published 2012
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  17. 17
    Costello and cardio‐facio‐cutaneous syndromes: Moving toward clinical trials in RASopathies

    Costello and cardio‐facio‐cutaneous syndromes: Moving toward clinical trials in RASopathies by Katherine A. Rauen, Anuradha Banerjee, W. Robert Bishop, Jennifer Lauchle, Frank McCormick, Martin McMahon, Teri Mélèse, Pamela N. Münster, Sorena Nadaf, Roger J. Packer, Judith S. Sebolt‐Leopold, David Viskochil

    Published 2011
    Get full text
    Artigo
    Save to List
    Saved in:
  18. 18
    Hyperactive Ras/MAPK signaling is critical for tibial nonunion fracture in neurofibromin-deficient mice

    Hyperactive Ras/MAPK signaling is critical for tibial nonunion fracture in neurofibromin-deficient mice by Richa Sharma, Xiaohua Wu, Steven D. Rhodes, Shi Chen, Yongzheng He, Jin Yuan, Jiliang Li, Xianlin Yang, Xiaohong Li, Li Jiang, Edward T. Kim, David A. Stevenson, David Viskochil, Mingjiang Xu, Feng‐Chun Yang

    Published 2013
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  19. 19
    Histopathologic evaluation of atypical neurofibromatous tumors and their transformation into malignant peripheral nerve sheath tumor in patients with neurofibromatosis 1—a consensus overview

    Histopathologic evaluation of atypical neurofibromatous tumors and their transformation into malignant peripheral nerve sheath tumor in patients with neurofibromatosis 1—a consensu... by Markku Miettinen, Cristina R. Antonescu, Christopher D.�M. Fletcher, AeRang Kim, Alexander J. Lazar, Martha Quezado, Karlyne M. Reilly, Anat Stemmer‐Rachamimov, Douglas R. Stewart, David Viskochil, Brigitte C. Widemann, Arie Perry

    Published 2017
    Get full text
    Revisão
    Save to List
    Saved in:
  20. 20
    cDNA sequence and genomic structure of EVI2B, a gene lying within an intron of the neurofibromatosis type 1 gene

    cDNA sequence and genomic structure of EVI2B, a gene lying within an intron of the neurofibromatosis type 1 gene by Richard Cawthon, Lone B. Andersen, Arthur M. Buchberg, Gangfeng Xu, P. OʼConnell, David Viskochil, Robert B. Weiss, Margaret R. Wallace, Douglas A. Marchuk, Melanie Culver, Jeffrey Stevens, Nancy A. Jenkins, Neal G. Copeland, Francis S. Collins, R. White

    Published 1991
    Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: